Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mel...

por Qiu, Rong, Capuano, George, Meininger, Gary
Publicado 2014

Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes

por Qiu, Rong, Balis, Dainius, Capuano, George, Xie, John, Meininger, Gary
Publicado 2016

Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes

por Rosenstock, Julio, Aggarwal, Naresh, Polidori, David, Zhao, Yue, Arbit, Deborah, Usiskin, Keith, Capuano, George, Canovatchel, William
Publicado 2012

Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial

por Fulcher, Greg, Matthews, David R., Perkovic, Vlado, de Zeeuw, Dick, Mahaffey, Kenneth W., Weiss, Robert, Rosenstock, Julio, Capuano, George, Desai, Mehul, Shaw, Wayne, Vercruysse, Frank, Meininger, Gary, Neal, Bruce
Publicado 2015

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results From t...

por Mahaffey, Kenneth W., Jardine, Meg J., Bompoint, Severine, Cannon, Christopher P., Neal, Bruce, Heerspink, Hiddo J.L., Charytan, David M., Edwards, Robert, Agarwal, Rajiv, Bakris, George, Bull, Scott, Capuano, George, de Zeeuw, Dick, Greene, Tom, Levin, Adeera, Pollock, Carol, Sun, Tao, Wheeler, David C., Yavin, Yshai, Zhang, Hong, Zinman, Bernard, Rosenthal, Norman, Brenner, Barry M., Perkovic, Vlado
Publicado 2019